What's new

Orphan designation: Alvelestat Treatment of congenital alpha-1 antitrypsin deficiency, 16/01/2025 Positive

Orphan designation: Alvelestat Treatment of congenital alpha-1 antitrypsin deficiency, 16/01/2025 Positive

Feb 20, 2025 - 14:46
 0
Orphan designation: Alvelestat Treatment of congenital alpha-1 antitrypsin deficiency, 16/01/2025 Positive
Orphan designation: Alvelestat Treatment of congenital alpha-1 antitrypsin deficiency, 16/01/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: Elraglusib Treatment of pancreatic cancer, 16/01/2025 Positive

Next Article

Tesla 'Violated' Workplace Safety Before Worker Death

Related Posts

Summary of opinion: Abrysvo, 27/02/2025 Positive

Summary of opinion: Abrysvo, 27/02/2025 Positive

Feb 28, 2025  0

Records of data processing activity regarding the proce...

Feb 14, 2025  0

Members of the Coordinating group of European network o...

Feb 10, 2025  0